AwardTape · Defense awards · Research and development · Defense systems R&D · W911SR20C0031
W911SR20C0031: -$1.5M definitive contract to Massachusetts Institute of Technology
Massachusetts Institute of Technology holds a definitive contract from Department of the Army with -$1.5M obligated since Oct 2023 and $1.5M obligated over its life, against a ceiling of $3.0M. Latest action Oct 16, 2023.
The overall objective of this effort is to develop a broad-spectrum, biologically derived, genetically tunable, high surface area, carbon based material that is capable of adsorbing and neutralizing chemical threats of interest to the DOD.
| PIID | W911SR20C0031 |
|---|---|
| Type | definitive contract |
| Company | Massachusetts Institute of Technology |
| Agency | Department of the Army |
| Contracting office | W6QK ACC-APG |
| Category | Research and development · Defense systems R&D |
| PSC | AD22 SERVICES (APPLIED/EXPLORATORY) |
| NAICS | 611310 COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS |
| Obligated since Oct 2023 | -$1.5M |
| Total obligated (lifetime) | $1.5M |
| Ceiling (base and all options) | $3.0M |
| Base date | May 29, 2020 |
| Latest action | Oct 16, 2023 |
| End date | May 31, 2023 |
| Actions since Oct 2023 | 1 |
| Pricing | Cost no fee |
| Competition | Full and open competition |
| Place of performance | MA |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial